- $1.05m
- $9.58m
- $4.35m
Prophase Labs Inc reports results for the quarter - Earnings Summary
Brief: ProPhase Labs Q3 Operating Income USD -7.937 Million
Brief: Prophase Labs Inc Files For Mixed Shelf Of Up To $291.6 Million - SEC Filing
Prophase Labs Inc expected to post earnings of 4 cents a share - Earnings Preview
Brief: ProPhase Labs Announces Positive Updates On Strategic Initiatives Company Anticipates Multiple Liquidity Events In H1 2025
Prophase Labs Inc reports results for the quarter ended in June - Earnings Summary
Brief: ProPhase Labs Q2 Net Income USD -6.153 Million
Prophase Labs Inc expected to post a loss of 24 cents a share - Earnings Preview
Prophase Labs Inc expected to post a loss of 24 cents a share - Earnings Preview
Brief: PROPHASE LABS ANNOUNCES UPDATE ON PHARMALOZ MANUFACTURING
Brief: Prophase Labs Announces Update On Pharmaloz Manufacturing Progress
Brief: ProPhase Labs Q1 Net Income USD -6.265 Million
Brief: ProPhase Labs Aiming For Commercial Launch Of BE-Smart Test For Esophageal Cancer In H2 2024
Prophase Labs Inc reports results for the quarter ended in December - Earnings Summary
Prophase Labs Inc expected to post a loss of 26 cents a share - Earnings Preview
Brief: Prophase Labs Announces Preliminary Positive Results For Dietary Supplement Equivir
Brief: ProPhase Labs Q3 Revenue USD 8.365 Million
Brief: ProPhase Lab Unveils Substantial Expansion Strategy For Pharmaloz Manufacturing
Prophase Labs Inc reports results for the quarter ended in June - Earnings Summary